Why 63% of Health Systems Use AI in the Revenue Cycle — and Only 15% Can Prove It Worked
63% of healthcare organizations have integrated AI into the revenue cycle. Only 15% can demonstrate ROI. The 48-point gap is a delivery problem — and delivery problems have known fixes.
Published by COIT24/7 on August 6, 2026.
Frequently asked questions
What is the healthcare RCM AI ROI gap?
It is the gap between organizations that have adopted AI somewhere in the revenue cycle and those that can prove financial return. In HFMA / FinThrive survey data, 63% report AI-powered automation in at least one RCM workflow, while only 15% report positive ROI — a 48-point gap.
Why do many health systems use AI in revenue cycle but still struggle to prove ROI?
Because adoption is easier than measurement. Many organizations launch AI into one or more workflows, but still lack a stable baseline, a named owner, or a clean way to connect operational changes back to financial outcomes like cost-to-collect or denial reduction.
Why is healthcare AI ROI so hard to prove?
Definitions drift, pilots run on thin data, and activity metrics get mistaken for business outcomes. Without an agreed baseline and an owner for each metric before go-live, even a useful tool can look unprovable to finance.
What metrics should a healthcare RCM AI project track first?
Start with a short list of business metrics that finance and operations already care about: initial denial rate, first-pass yield, cost-to-collect, net revenue impact, and rework time by team. Tool activity alone is not enough.
What is the biggest mistake in healthcare AI pilots for revenue cycle?
Treating a pilot like a demo instead of the first slice of production. If the integration path, review steps, data definitions, and owners are not decided early, the pilot may “work” but still never scale cleanly.
How should a healthcare organization choose the first RCM AI workflow to improve?
Pick one workflow with a visible operational burden and a measurable business outcome. Denials, eligibility, documentation, and coding are common starting points, but the right choice depends on where the current leakage is largest and easiest to baseline.
What does a 90-day RCM AI diagnostic include?
Days 1–30 establish three owned baseline metrics. Days 31–60 inventory live AI tools and map top denial reasons to upstream causes. Days 61–90 decide which failure mode you are in before buying another product — then scope the next move.
How do top health systems govern AI use cases in revenue cycle?
They treat AI intake like capital allocation: some use cases are approved, some are rejected. CommonSpirit’s fiscal reporting highlighted hundreds of live applications alongside explicit rejections through governance review — rejection is part of the ROI discipline.